Immunovant, Inc. (IMVT): Shares Outstanding
203.94M
As of 2026-03-31
206.26M
As of 2026-06-30
+16.1%
3-year compound annual growth
+15.8%
5-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2026-03-31 | 203.94M | +19.9% | 2026-05-20, Balance as of period end |
| 2025-03-31 | 170.11M | +16.8% | 2026-05-20, Balance as of period end |
| 2024-03-31 | 145.58M | +11.7% | 2025-05-29, Balance as of period end |
| 2023-03-31 | 130.33M | +11.9% | 2024-05-29, Balance as of period end |
| 2022-03-31 | 116.48M | +18.9% | 2023-05-22, Balance as of period end |
| 2021-03-31 | 97.97M | +79.3% | 2022-06-08, Balance as of period end |
| 2020-03-31 | 54.66M | +41.6% | 2021-06-01, Balance as of period end |
| 2019-03-31 | 38.59M | n/a | 2020-06-29, Balance as of period end |